Objectives

Corporate document

This statement of intent outlines our approach to develop and test methods to support the use and evaluation of artificial intelligence (AI) at NICE. The work falls into 3 main priority areas:

providing guidance for technology developers on best practice for AI-based methods to support evidence generation
evaluating technologies that incorporate AI, such as clinical prediction models, decision support systems, diagnostics, or digital health technologies
exploring the use of AI to support and improve the efficiency of NICE's internal processes.

Developing evidence requirements and piloting new tools in these priority areas will require close collaboration with key experts and stakeholders, including healthcare professionals, patients, researchers and life sciences industry representatives.